Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Will Pfizer Inc. Make A Bid For GlaxoSmithKline plc?

    | Rupert Hargreaves

    Will Pfizer Inc. (NYSE:PFE) bid for GlaxoSmithKline plc (LON: GSK) or AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    Is AstraZeneca plc The #1 Healthcare Play Today?

    | Peter Stephens

    After an encouraging update, does AstraZeneca plc (LON: AZN) now rule the healthcare space?

    Read more »

    Investing Articles

    3 Super-Defensive Shares I’d Buy With £10,000: United Utilities Group PLC, Unilever plc And AstraZeneca plc

    | Peter Stephens

    Here’s why United Utilities Group PLC (LON: UU), Unilever plc (LON: ULVR) and AstraZeneca plc (LON: AZN) could protect your…

    Read more »

    Investing Articles

    3 Things That Say AstraZeneca plc Is A Buy

    | Alan Oscroft

    AstraZeneca plc (LON: AZN) looks pricey, but could still be a bargain.

    Read more »

    Investing Articles

    The Buy Case For GlaxoSmithKline plc Is Getting Stronger Every Day

    | Rupert Hargreaves

    GlaxoSmithKline plc (LON: GSK) is cheap compared to close peer AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    Eyes Down For AstraZeneca plc Results

    | Alan Oscroft

    It's first-half time for drugs giant AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    Should You Buy GlaxoSmithKline plc Or AstraZeneca plc?

    | Peter Stephens

    After releasing disappointing results today, is GlaxoSmithKline plc (LON: GSK) still a better buy than AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    Neil Woodford’s Risky Portfolio, ft. AstraZeneca plc And Imperial Tobacco Group PLC

    | Alessandro Pasetti

    AstraZeneca plc (LON:AZN), BT Group plc (LON:BT-A), Rolls-Royce plc (LON: RR) and Imperial Tobacco plc (LON:IMT) are a bet on…

    Read more »

    Investing Articles

    How AstraZeneca plc Can Pay Off Your Mortgage

    | Peter Stephens

    AstraZeneca plc (LON: AZN) has potential. And it could help pay off your mortgage. Here’s how.

    Read more »

    Investing Articles

    The Rising Pound Will Hit GlaxoSmithKline plc, BHP Billiton plc, ARM Holdings Plc, AstraZeneca plc And Diageo plc

    | Harvey Jones

    The strong pound has a sting in the tail for investors in GlaxoSmithKline plc (LON:GSK), BHP Billiton plc (LON:BLT), ARM…

    Read more »

    Investing Articles

    Is Roche Eyeing Up A Bid For AstraZeneca plc?

    | Rupert Hargreaves

    Another buyer could be eyeing up AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    One Reason Why AstraZeneca plc Is A Risky Bet

    | Alessandro Pasetti

    It's tough for AstraZeneca plc (LON:AZN) shareholders, argues Alessandro Pasetti.

    Read more »